Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
02/2008
02/12/2008CA2090485C Method and apparatus for the rapid synthesis of substrate-bound or free peptides or oligonucleotides, flat material synthesized in this way and the use of such material
02/07/2008WO2008017081A1 Compositions and methods for the modulation of jnk proteins
02/07/2008WO2008016988A1 Methods of nonspecific target capture of nucleic acids
02/07/2008WO2008016909A2 Nucleotide analogs
02/07/2008WO2008016907A1 Nucleotide analogs
02/07/2008WO2008016686A2 Enhanced broad-spectrum uv radiation filters and methods
02/07/2008WO2008015577A2 Sensizitation of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
02/07/2008WO2008014979A2 NUCLEIC ACID OF FORMULA (I): GIXmGn, OR (II): CIXmCn, IN PARTICULAR AS AN IMMUNE-STIMULATING AGENT/ADJUVANT
02/07/2008WO2007143245A3 An l-arabinose fermenting yeast
02/07/2008WO2007133831A3 High throughput genome sequencing on dna arrays
02/07/2008WO2007113683A3 Modulation of tc10 function and method of treating glucose metabolic disorders
02/07/2008WO2006091969A3 Predicting chemosensitivity to cytotoxic agents
02/07/2008US20080034455 Production Of A Protein Localized To The Endoplasmic Reticulum Protein Bodies In A Transgenic Plant And Seed
02/07/2008US20080034453 Nucleotide sequences coding maize and/or soybean proteinfor use in genome mapping, identification and analysis; plant breeding
02/07/2008US20080034451 Rice Pollen-Preferential Promoters And Uses Thereof
02/07/2008US20080033161 Method for extracting nucleic acid
02/07/2008US20080033159 Method for small volume nucleic acid synthesis
02/07/2008US20080033158 using two to (n) purification columns to separate full length 5'-DMT-on oligonucleotides with size ranging from 40 to 180-mers from short length 5'-DMT-on oligonucleotides
02/07/2008US20080033157 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
02/07/2008US20080033156 Short interfering nucleic acid (siNA) molecule and a polyamine compound having guanidinium, amine, or histidyl end groups and optionally containing polyether groups; biodrug delivery
02/07/2008US20080033061 Cation conducting gabaa receptors and their use
02/07/2008US20080032947 Pka ligands and polynucleotides encoding pka ligands
02/07/2008US20080032946 Method for producing a composite made of oligonucleotides or polynucleotides and hydrophobic biodegradable polymers as well as composite obtained according to the method
02/07/2008US20080032945 2'-modified oligonucleotides
02/07/2008US20080032944 Target Nucleic Acid Of Retrovirus Integration
02/07/2008US20080032942 double-stranded (siNA) molecule that down-regulates expression of a beta-secretase (BACE) gene
02/07/2008US20080032931 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
02/07/2008US20080032930 Single-chain polypeptide fusion comprising functional binding, translocation and clostridial neurotoxin heavy chain domain for use as therapeutic agents and/or transporter molecules
02/07/2008US20080032928 Treatment of mucus hypersecretion
02/07/2008US20080032927 Treatment of development-related disorders
02/07/2008US20080032921 Inducing immune responses to influenza virus using polypeptide and nucleic acid compositions
02/07/2008US20080032920 Macromolecules modified with electrophilic groups and methods of making and using thereof
02/07/2008US20080032919 BMP-7 Variant Compositions, Methods and Uses
02/07/2008US20080032413 Oligonucleotide For Detecting Target Dna Or Rna
02/07/2008US20080032399 Method and kits for preparing multicomponent nucleic acid constructs
02/07/2008US20080032386 Stabilized Proline Transporter
02/07/2008US20080032385 Novel antimicrobial peptide isolated from Penaeus monodon
02/07/2008US20080032369 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms ; plants and microorganisms that produce lipids
02/07/2008US20080032368 Pufa polyketide synthase systems and uses thereof
02/07/2008US20080032367 Isolated nucleic acid molecule encoding an amino acid sequence with beta -ketoacyl-ACP synthase (KS) activity; polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems from bacterial microorganisms; plants and microorganisms that produce lipids
02/07/2008US20080032351 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
02/07/2008US20080032346 Method of increasing complementarity in a heteroduplex
02/07/2008US20080032340 Peptide motifs for binding avidin or neutravidin
02/07/2008US20080032339 Using transgenic escherichia as bioreactor for producing immunoglobulins specific to streptococcal capsular protein for use in treatment and prevention of bacterial infection
02/07/2008US20080032338 polyunsaturated fatty acid (PUFA) polyketide synthase (PKS) systems having greater flexibility for commercial use; for the production of bioactive molecules of interest
02/07/2008US20080032337 Genetic engineering; analyze the corresponding expression products, elucidate the pathology of diseases associated with the genes, for example hereditary diseases and cancer, and diagnose and treat such diseases
02/07/2008US20080032336 Chemokine receptor materials and methods
02/07/2008US20080032335 Provides polypeptide having wide substrate specificity and having omega 3 fatty acid desaturation activity, which makes efficiently unsaturated bond at omega 3 position, and a polynucleotide coding for the same; by expressing the polypeptide in the organism, mass production of n-3 series PUFAs is enabled
02/07/2008US20080032332 Wound healing agents; anticancer agents; cardiovascular disorders
02/07/2008US20080032323 Nucleic Acid Construct Containing a Nucleic Acid Derived From the Genome of Hepatitis C Virus (Hcv) of Genotype 2A, and a Cell Having Such Nucleic Acid Construct Introduced Therein
02/07/2008US20080032320 Method of Screening Compound Capable of Accelerating or Inhibiting Apoptosis, Apoptosis Accelarator and Apoptosis Inhibitor
02/07/2008US20080032304 FULL-LENGTH cDNA AND POLYPEPTIDES
02/07/2008US20080032300 Lupac Bifunctional Marker and Its Use in Protein Production
02/07/2008US20080032296 Sequences with FabA-like beta -hydroxyacyl-ACP dehydrase (DH) activity; biosynthesis of polyunsaturated fatty acids (PUFAs)
02/07/2008US20080032288 Labeling Reagents, Methods for the Synthesis of Such Reagents and Methods for the Detection of Biological Molecules
02/07/2008US20080032286 Competition Assay for Identifying Modulators of Quadruplex Nucleic Acids
02/07/2008US20080032285 using a replication composition in the form of a tablet, and a detection kit to perform of RT-PCR; highly sensitive assay for that broadly detects most strains of the virus, is rapid, accurate and easily performed
02/07/2008US20080032280 Method and Kits for Detecting Human Cytomegalovirus
02/07/2008US20080031952 Nucleic Acid Comprising a Sequence Encoding a Modified Glutenin Polypeptide
02/07/2008US20080031936 Immunostimulatory nucleic acid molecules
02/07/2008US20080031878 Polypeptides for the Diagnosis and Therapy of Leishamaniasis
02/07/2008US20080031853 treating Hepatitis-C virus; covalently attached to a nonpeptide polyoxyethylene glycol moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; drugs/polymer conjugates/ as viricides
02/07/2008US20080030713 Uncaging devices
02/07/2008DE102006035618A1 New nucleic acid useful as immuno-stimulating adjuvant for manufacture of a composition for treatment of cancer diseases e.g. colon carcinomas and infectious diseases e.g. influenza and malaria
02/07/2008CA2660052A1 Compositions and methods for the modulation of jnk proteins
02/07/2008CA2659301A1 Dinucleotide mrna cap analogs
02/07/2008CA2658105A1 Methods of nonspecific target capture of nucleic acids
02/07/2008CA2643136A1 Installation of genomes or partial genomes into cells or cell-like systems
02/06/2008EP1884569A1 Sensitization of cancer cells to therapy using siNA targeting genes from the 1p and 19q chromosomal regions
02/06/2008EP1883709A2 Human micrornas and methods for inhibiting same
02/06/2008EP1883697A2 Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors
02/06/2008EP1883427A2 Compositions and methods for studying and treating inflammatory diseases and disorders
02/06/2008EP1651770B1 Promoter molecules for use in plants
02/06/2008CN101120098A Method for nucleic acid analysis
02/06/2008CN101120092A Co-expression of multiple protein chains or subunits
02/06/2008CN101117344A Isolation of rna and DNA from a biological sample
02/06/2008CN100366730C Promoter and plasmid system for genetic engineering
02/06/2008CN100366631C IgG Fc/HIV-gp120/C3d fusion protein
02/05/2008US7326954 Scaffold-organized metal, alloy, semiconductor and/or magnetic clusters and electronic devices made using such clusters
02/05/2008US7326828 Construction of a recombinant DNA construct encoding the phospholipid, in sense or antisense orientation, wherein expression of the recombinant DNA construct results in production of altered levels of the phospholipid
02/05/2008US7326783 Genetic engineering
02/05/2008US7326781 Polynucleotides encoding the human citron kinase polypeptide, BMSNKC—0020/0021
02/05/2008US7326780 Label (fluorescence-emitting molecule, hapten-containing molecule, protein, or radioactive chemical) attached to N-(2-chloroethyl)-N-methylaminobenzylamino ligand by a spacer forming a neutralized quaternary ammonium group for covalent attachment to DNA, RNA, or siRNA
02/05/2008US7326779 Primers and method of detecting bacteria
02/05/2008US7326773 PRO6493 antibodies
02/05/2008US7326771 Fluorescent proteins from coelentrates (Corynactis californica), genes encoding the proteins and variants, having unique absorption and emission spectra
02/05/2008US7326693 Antisense modulation of c-reactive protein expression
02/05/2008US7326575 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization
02/05/2008US7326567 Plasmid system for multigene expression
02/05/2008US7326566 Compositions and methods for screening antimicrobials
02/05/2008US7326557 Increasing intracellular NADPH availability in E. coli
02/05/2008US7326553 Maltose-1-phosphate-producing enzyme
02/05/2008US7326551 Nucleotide sequences coding polypeptide for use in generation of bacteria which generate synthetic fuels
02/05/2008US7326548 starch conversion for producing fermentation products, such as ethanol, and syrups, such as glucose; fusion polypeptide; mixture with alpha-amylase
02/05/2008US7326547 Irradiated plant mutant which generates seed oil with reduced concentrations of polyunsaturated fatty acids
02/05/2008US7326545 Chlamydia antigens and corresponding DNA fragments and uses thereof
02/05/2008US7326544 Reagents for diagnosis of bacterial infection, components of antibacterial vaccines, and/or as targets for antibacterial drugs
02/05/2008US7326543 Gene encoding protein from merozoite of Babesia caballi, recombinant protein obtained with said gene and use thereof
02/05/2008US7326537 In human blood, urine, saliva, tissue biopsy or autopsy material; immunoassay using a mono- or polyclonal antibody; detecting overexpression; diagnosis
02/05/2008US7326533 Amplifying the sequence in vitro in a nucleic acid amplification mixture that includes specific primer sequences, and detecting the amplified sequences using probes that provide information by their specific hybridization to portions of the amplified nucleic acid